Project publicity

Bulk Drug and Intermediate Reconstruction and Expansion Project (QC Testing Center) Project Publicity

Bulk Drug and Intermediate Reconstruction and Expansion Project (QC Testing Center) Project Publicity
According to the Decision of the State Council on Amending the Regulations on the Administration of Environmental Protection for the Completion of Construction Projects (Order No. 682 of the State Council) and the Announcement of the Ministry of Environmental Protection on Issuing the Interim Measures for the Acceptance of Environmental Protection for the Completion of Construction Projects (No. 4 [2017] of the State Environmental Regulations), the Acceptance Monitoring Report on the Reconstruction and Expansion Project of Raw Materials and Intermediates of Dejia Pharmaceutical Group Co., Ltd. (QC Testing Center) is hereby published as follows:
Project Name: Reconstruction and Expansion Project of API and Intermediate (QC Testing Center)
Construction unit: Degas Pharmaceutical Group Co., Ltd.
Publicity content: environmental protection acceptance monitoring report and acceptance opinions of construction project completion
baidu network disk link:
Publicity time: October 21, 2025-November 17, 2025
During the publicity period, if you have any objection to the above publicity contents, please give feedback in writing. The individual must sign his real name and the unit must affix his official seal.
Contact: Manager Zhao
Tel: 0631-3783153
Address: No. 268, Tianrun Road, Wendeng Economic Development Zone, Weihai City
The project acceptance monitoring report and acceptance opinions are downloaded in electronic form through Baidu website
Link: https://pan.baidu.com/s/1Hgmdj9tctqRQt5kAqfBHOg?pwd=gpt9
Extraction code: gpt9